Aristro Capital Markets Ltd.
You Are On :   Home  |  Equity  |   Company Profile  |  Board Meetings
 
Equity
Equity Analysis
Price
Volume
Analysis
News Analysis
Corporate Action
Other Market
Company Profile
Board Meetings
Jyoti Structures Ltd.
 
BSE Code 513250
ISIN Demat INE197A01024
Book Value (Rs.) 4.27
NSE Code JYOTISTRUC
Dividend Yield  % 0.00
Market Cap  (Rs. Mn) 12700.54
TTM PE (x) 19.74
TTM EPS (Rs.) 0.54
Face Value (Rs.) 2  
Source DateBoard Meeting DateDetails
30-Jul-2026 04-Aug-2026 Quarterly Results
27-Apr-2026 30-Apr-2026 Audited Results
20-Jan-2026 23-Jan-2026 Quarterly Results
07-Nov-2025 12-Nov-2025 Quarterly Results
25-Sep-2025 30-Sep-2025 Inter alia, to consider and approve:- 1. To take on record and deliberate upon the Letter of Intent (LOI) received from Telexcell Trade PTE LTD, Singapore, for a proposed acquisition of up to 25% equity stake in Welcure Drugs & Pharmaceuticals Ltd. at an indicative price of Rs.20 per share (a substantial premium over the prevailing market price). 2. To initiate the process of comprehensive due diligence in respect of the proposed transaction, including legal, financial, and regulatory aspects. 3. To consider authorizing the Company's representatives to negotiate and finalize the terms of definitive agreements, in alignment with Welcure's long-term growth strategy and compliance with applicable regulatory frameworks. 4. To explore enabling mechanisms for shareholder approval through postal ballot / general meeting, in line with SEBI, RBI, FEMA, and stock exchange requirements. 5. To deliberate on future strategic growth opportunities in global pharmaceutical and chemical exports, leveraging Telexcell's global trade network.
11-Aug-2025 14-Aug-2025 Quarterly Results & Inter alia to consider, approve and take on record the following matters: 1. Appointment of Branch Auditors. 2. Appointment/Re-appointment of Internal Auditors. 3. Appointment of Secretarial Auditor. 4. Directors Report for the financial year 2024-2025. 5. Allotment of Equity Shares under ESOS Scheme 2021. 6. Any other matter with the permission of the Chairperson.
23-May-2025 28-May-2025 Audited Results
22-Apr-2025 25-Apr-2025 Inter alia, to consider and approve:- 1.Allotment of Equity Shares under ESOS Scheme 2021. 2.Any other matter with the permission of Chairperson.
29-Jan-2025 03-Feb-2025 Quarterly Results
18-Nov-2024 22-Nov-2024 Rights Issue & Inter alia, to consider and transact the following businesses: (1) fund raising by way of equity shares or other securities through rights issue as may be permitted under applicable law(s), subject to such regulatory/statutory approvals as may be required and other related matters.
close X

Download Client Registration Documents

Client Registration Documents in Vernacular Languages

Member: NSE CAPITAL MARKET: INB231498438 | NSE FUTURE & OPTION: INF231498438 | BSE CAPITAL MARKET: INB011498434 | BSE FUTURE MARKET: INF011498434 | DP REGN No.:IN-DP-CDSL-704-2013 | Single SEBI Registration nos.: NSE & BSE: INZ000219238 | DP CDSL: IN-DP-407-2019
Attention Investor: Update your mobile number and email id with your stock broker.
Home| About Us | Services | Login | Research | Online Trading | Customer Support | Useful links | SEBI SCORE | Contact Us | Investor Charter | Share Links:  
Terms & Conditions |Disclaimer | Privacy Policy |Policy & Procedure | Feedback | Open An Account | Downloads |Customer Desk |Policy |Site Map |Segregation and Monitoring of Collateral
NSE | BSE | SEBI | NSDL | NCDEX | CDSL | MCX | NMCE | MCX-SX | RBI | Do & Don'ts | CDSL Circular | CDSL e-Voting | Rights & Obligations | Risk Disclousre Document
Details of Authorised Persons | Basic Details | SMART ODR | Policy on Handling of GTC Orders | Saral Account opening form | Rights and Obligation for DP
QR Code for DP | QR Code for Stock Broker | ARISTRO MGT7 | CSR Policy Aristro | Investor Charter-Stock Broker | Grievance
Copyright Aristro Capital Markets Ltd. All Rights Reserved.
Designed, Developed & Content Powered By  Accord Fintech Pvt. Ltd.